BrightGene Bio-Medical Technology Co Ltd banner

BrightGene Bio-Medical Technology Co Ltd
SSE:688166

Watchlist Manager
BrightGene Bio-Medical Technology Co Ltd Logo
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Watchlist
Price: 49.52 CNY 6.52% Market Closed
Market Cap: ¥21B

Cash Flow Statement

Cash Flow Statement
BrightGene Bio-Medical Technology Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Cash Taxes Paid
(0)
(6)
(7)
(5)
2
4
10
10
7
8
7
2
16
29
17
13
(19)
(32)
(29)
(22)
(21)
(25)
(25)
(21)
(17)
(19)
Change in Working Capital
(266)
(192)
(209)
(230)
(222)
(207)
(228)
(233)
(282)
(350)
(348)
(391)
(391)
(401)
(440)
(464)
(458)
(480)
(433)
(404)
(474)
(474)
(535)
(531)
(550)
(599)
Cash from Operating Activities
67
N/A
41
-39%
61
+49%
70
+15%
117
+66%
144
+23%
155
+8%
164
+5%
109
-33%
149
+36%
176
+18%
143
-19%
207
+45%
299
+45%
311
+4%
366
+18%
319
-13%
204
-36%
195
-5%
318
+63%
294
-8%
216
-27%
246
+14%
204
-17%
208
+2%
225
+8%
Investing Cash Flow
Capital Expenditures
(152)
(62)
(90)
(108)
(149)
(194)
(355)
(602)
(765)
(914)
(910)
(964)
(872)
(833)
(727)
(541)
(480)
(389)
(404)
(366)
(371)
(354)
(257)
(360)
(393)
(370)
Other Items
(117)
(76)
(67)
4
(236)
(199)
(187)
(101)
71
5
20
(344)
(249)
(192)
(145)
74
(67)
(56)
(36)
27
(17)
(143)
(183)
(169)
(143)
(198)
Cash from Investing Activities
(269)
N/A
(138)
+49%
(156)
-13%
(105)
+33%
(384)
-267%
(393)
-2%
(542)
-38%
(703)
-30%
(695)
+1%
(909)
-31%
(890)
+2%
(1 307)
-47%
(1 121)
+14%
(1 024)
+9%
(872)
+15%
(467)
+46%
(547)
-17%
(445)
+19%
(440)
+1%
(339)
+23%
(388)
-15%
(497)
-28%
(440)
+11%
(529)
-20%
(536)
-1%
(568)
-6%
Financing Cash Flow
Net Issuance of Debt
0
0
0
5
45
132
220
473
499
680
671
1 087
1 226
990
1 172
502
348
373
118
141
242
(26)
15
(15)
(75)
111
Cash Paid for Dividends
0
0
(0)
0
(34)
(34)
(35)
(37)
(38)
(47)
(54)
(61)
(90)
(95)
(100)
(100)
(118)
(114)
(115)
(136)
(69)
(133)
(136)
(126)
(172)
(110)
Other
0
0
440
0
0
441
1
0
0
7
87
0
147
140
293
353
293
288
58
(9)
(20)
(20)
96
297
351
442
Cash from Financing Activities
0
N/A
0
N/A
440
N/A
445
+1%
451
+1%
539
+20%
186
-66%
437
+135%
463
+6%
639
+38%
704
+10%
1 112
+58%
1 282
+15%
1 034
-19%
1 365
+32%
756
-45%
523
-31%
548
+5%
62
-89%
(5)
N/A
153
N/A
(179)
N/A
(24)
+86%
156
N/A
104
-33%
443
+326%
Change in Cash
Effect of Foreign Exchange Rates
3
3
2
4
2
(4)
(13)
(9)
(12)
(8)
4
(1)
2
6
14
11
13
6
3
7
6
8
2
4
7
7
Net Change in Cash
51
N/A
130
+157%
347
+166%
415
+20%
185
-55%
286
+54%
(214)
N/A
(112)
+48%
(134)
-20%
(130)
+4%
(6)
+95%
(53)
-745%
370
N/A
316
-15%
819
+159%
665
-19%
309
-54%
312
+1%
(181)
N/A
(18)
+90%
64
N/A
(453)
N/A
(217)
+52%
(165)
+24%
(217)
-32%
107
N/A
Free Cash Flow
Free Cash Flow
(85)
N/A
(21)
+76%
(28)
-38%
(38)
-35%
(32)
+16%
(50)
-57%
(200)
-300%
(439)
-120%
(656)
-49%
(766)
-17%
(734)
+4%
(821)
-12%
(665)
+19%
(533)
+20%
(415)
+22%
(176)
+58%
(161)
+8%
(185)
-15%
(209)
-13%
(48)
+77%
(77)
-60%
(139)
-80%
(12)
+92%
(156)
-1 241%
(185)
-18%
(145)
+22%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett